Eli Lilly Q4 2024 Earnings Preview: All eyes on stronger 2025
jetcityimage/iStock Editorial via Getty Images Eli Lilly (NYSE:LLY) is scheduled to announce Q4 earnings results
jetcityimage/iStock Editorial via Getty Images Eli Lilly (NYSE:LLY) is scheduled to announce Q4 earnings results
FotografiaBasica/E+ via Getty Images Novo Nordisk (NVO) said on Wednesday that its emissions rose by
hapabapa/iStock Editorial via Getty Images Novo Nordisk (NVO) reported better-than-expected operating profits for Q4 2024
matdesign24 While Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) still rule the weight-loss drug market
2d illustrations and photos Shares of newly public Metsera (NASDAQ:MTSR), which is developing ultra-long-acting obesity
Win McNamee/Getty Images News In words that are sure to please executives at Novo Nordisk
Baris-Ozer Shares of Tectonic Therapeutic (NASDAQ:TECX) plunged on Tuesday after a federal website on clinical
hapabapa Novo Nordisk (NVO) said its popular diabetes drug Ozempic, also known as semaglutide, has
2d illustrations and photos/iStock via Getty Images Metsera (MTSR), which is developing ultra-long-acting drugs for
Victor Golmer Novo Nordisk (NVO) has reportedly settled a lawsuit filed by the state of